Luigi Mangione pleaded guilty on Friday to federal stalking charges related to the fatal shooting of UnitedHealthcare CEO Brian Thompson. The plea was entered during a pretrial conference before U.S. District Judge Margaret Garnett in Manhattan. The development occurs roughly two years after the shooting and weeks before a separate state-level trial is scheduled to begin.
The case stems from the shooting of Thompson as he entered the New York Hilton Midtown for an annual investors meeting. Following a five-day search, authorities arrested Mangione at a restaurant in Altoona, Pennsylvania. At the time of his arrest, officials reported finding a 9mm pistol with a silencer, a fake identification card, and a notebook containing grievances against the health insurance industry.
Mangione had previously pleaded not guilty to both federal and state charges. In January, Judge Garnett dismissed federal murder and firearm counts that carried potential death penalty eligibility, leaving only the stalking charges. In the state case, Mangione faces charges of second-degree murder and weapons offenses, though a judge dismissed terrorism charges last fall due to insufficient evidence.
The scale of the impact centers on the procedural integrity of two concurrent judicial systems. State prosecutors expressed concern in a July letter that a federal guilty plea could "defeat a just outcome" in the state's homicide case. Mangione's attorney, Karen Friedman Agnifilo, noted the rarity and potential confusion of a defendant facing simultaneous prosecutions in both federal and state jurisdictions for related conduct. While Judge Gregory Carro previously described double jeopardy arguments as premature, the plea forces a resolution on whether the state trial can proceed as planned.
A person following this case will notice a shift in the legal timeline. Instead of a full federal trial on stalking charges, the focus moves toward the state's second-degree murder case. The immediate next step is the selection of an anonymous jury for the state trial, currently scheduled to begin on September 8. The court must now determine if the federal plea creates a legal barrier to the state's prosecution or if the proceedings will continue as scheduled.
The defense and prosecution requested the conference that led to the plea earlier this week. Assistant Manhattan District Attorney Joel Seidemann argued that any resolution must account for the loss of life and the impact on the victim's family. The final sentencing for the federal charges and the commencement of the state trial remain the primary pending legal actions.